general
Translated · English · 2–5m lag
Cannabidiol Pharma 5 : five years of research and 200 MDH investment to treat refractory epilepsy
From the parcel to the vial of bubble solution, laboratories led by Mia and Yasmine Lahlou-Filli sell a completely Moroccan value chain. Back in five years of pharmaceutical and regulatory development. The essential in 3 p...
Reported by TelQuel
Read the complete report at TelQuel ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
TelQuelCannabidiol Pharma 5 : five years of research and 200 MDH investment to treat refractory epilepsyTelQuelCannabidiol Pharma 5 : five years of research and 200 MDH investment to treat refractory epilepsy6 recorded states
Signal first indexedP1 · 68% quality · 1 source
Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources